Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen

This study has been completed.
Information provided by:
Sanofi Identifier:
First received: March 10, 2008
Last updated: January 10, 2011
Last verified: January 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2003
  Estimated Primary Completion Date: No date given